/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products, healthcare supplies, and offering various services across the healthcare sector, both in the U.S. and internationally.
The prescription drug distributor is expected to release its fiscal Q2 2025 earnings results before the market opens on Wednesday, May 7. Ahead of this event, analysts expect COR to report an adjusted EPS of $4.07, up 7.1% from $3.80 in the prior year's quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarters.